Biopharmaceutical Firm Heals Itself From Short List.

0 Comments | M2 Presswire, September, 2005

M2 PRESSWIRE-30 September 2005-Emerging Stock Report: Biopharmaceutical Firm Heals Itself From Short List(C)1994-2005 M2 COMMUNICATIONS LTD RDATE:30092005 The Emerging Stock Report is following NOVAVAX (NASDAQ: NVAX), a specialty biopharmaceutical company, that engages in the research, development, and commercialization of products for women's health and infectious diseases.

The company stock showed a 22 gain today based on being removed from the NASDAQ, AMEX and NYSE naked short threshold lists. Novavax was formed in 1987 and is headquartered in Malvern, Pennsylvania. The company currently sells, markets and distributes a line of women's health prescription pharmaceuticals. The company sells its products to obstetricians, gynecologists, managed care...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)